Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

The overall 5 year survival rate for pancreatic ductal adenocarcinoma (ie, PDAC) is a dismal
5%, although patients that have undergone surgical resection have a somewhat better …

BACKGROUND The single‐payer universal health care system in Ontario, Canada creates
a setting with reduced socioeconomic barriers to treatment. Herein, the authors sought to …

Preoperative biliary drainage (PBD) has been thought to be preferable regardless of the site
of biliary strictures, eg, distal or proximal strictures because PBD by endoscopy or …

Background: Perineural invasion (PNI) has been reported as one of the sources of
locoregional recurrence in resected pancreatic cancer (PC). However the impact of PNI in …

Background: This study assesses the impact of preoperative chemoradiation on recurrence,
surgical morbidity, histopathological data and survival in resectable adenocarcinoma of the …

Aims This study is to examine the significance of the number and ratio of positive nodes in
post‐neoadjuvant therapy pancreaticoduodenectomy (PD) for pancreatic ductal …

Lymphovascular invasion (LVI) is a prognostic factor in many types of human malignancies,
including pancreatic ductal adenocarcinoma (PDAC). However, the prognostic significance …

Background Cell–cell adhesion molecules such as desmosomes and cytokeratins may play
a major role in epithelial–mesenchymal transition and have been suggested to have a …

Abstract Background/Aims: Body-tail pancreatic cancer is an aggressive disease with a low
resectability rate and a poor prognosis. Celiac axis invasion usually contraindicates …